Total Payments
$1,449
2024 Payments
$241.58
Companies
16
Transactions
62
Medicare Patients
885
Medicare Billing
$96,748
Payment Breakdown by Category
Food & Beverage$1,449 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,449 | 62 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $764.79 | 25 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $140.72 | 2 | $0 (2023) |
| ABBVIE INC. | $96.68 | 6 | $0 (2024) |
| Novo Nordisk Inc | $95.00 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $69.64 | 4 | $0 (2024) |
| SANOFI PASTEUR INC. | $60.50 | 4 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $45.11 | 5 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $29.20 | 2 | $0 (2024) |
| Corium, LLC | $25.77 | 1 | $0 (2024) |
| Axsome Therapeutics, Inc. | $22.76 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $241.58 | 13 | ABBVIE INC. ($51.54) |
| 2023 | $329.12 | 8 | GlaxoSmithKline, LLC. ($153.62) |
| 2022 | $139.31 | 9 | GlaxoSmithKline, LLC. ($66.39) |
| 2021 | $275.20 | 11 | GlaxoSmithKline, LLC. ($165.07) |
| 2020 | $216.63 | 9 | GlaxoSmithKline, LLC. ($192.11) |
| 2019 | $85.31 | 7 | GlaxoSmithKline, LLC. ($36.92) |
| 2018 | $135.69 | 2 | GlaxoSmithKline, LLC. ($124.74) |
| 2017 | $25.69 | 3 | Sunovion Pharmaceuticals Inc. ($13.91) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | NEXIUM (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Gastrointestinal | ||||||
| 11/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Biological | ||||||
| 09/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Oncology | ||||||
| 07/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: VACCINE | ||||||
| 06/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Obesity | ||||||
| 05/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Bone Health | ||||||
| 02/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/05/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $122.27 | General |
| 10/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Biological | ||||||
| 08/15/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Obesity | ||||||
| 04/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: RESPIRATORY | ||||||
| 03/10/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Obesity | ||||||
| 02/10/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardio-renal | ||||||
| 12/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Diabetes | ||||||
| 06/09/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 239 | 340 | $54,876 | $24,577 |
| 2022 | 4 | 186 | 278 | $48,808 | $22,318 |
| 2021 | 7 | 224 | 391 | $54,161 | $27,138 |
| 2020 | 7 | 236 | 356 | $51,875 | $22,714 |
Total Patients
885
Total Services
1,365
Medicare Billing
$96,748
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 145 | $29,580 | $11,312 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $10,738 | $7,228 | 67.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 77 | $11,088 | $3,774 | 34.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 21 | 21 | $2,520 | $1,609 | 63.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 38 | 38 | $950.00 | $654.74 | 68.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 120 | $24,480 | $9,511 | 38.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 56 | 56 | $10,192 | $7,010 | 68.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 79 | $11,376 | $4,084 | 35.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 23 | 23 | $2,760 | $1,713 | 62.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 118 | $23,304 | $10,156 | 43.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 45 | 45 | $8,190 | $5,852 | 71.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 75 | $10,173 | $4,896 | 48.1% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 39 | 39 | $4,650 | $3,195 | 68.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 14 | 91 | $6,825 | $2,229 | 32.7% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 12 | 12 | $700.00 | $631.82 | 90.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $319.00 | $177.43 | 55.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 67 | 129 | $23,868 | $8,672 | 36.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 66 | 66 | $12,012 | $7,423 | 61.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 54 | 103 | $12,826 | $4,593 | 35.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 16 | 16 | $1,440 | $1,250 | 86.8% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 11 | 18 | $1,215 | $561.04 | 46.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 11 | $319.00 | $176.78 | 55.4% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 11 | 13 | $195.00 | $37.72 | 19.3% |
About Dr. Jennifer Lyon, D.O
Dr. Jennifer Lyon, D.O is a Sports Medicine healthcare provider based in Traverse City, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1528283199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Lyon, D.O has received a total of $1,449 in payments from pharmaceutical and medical device companies, with $241.58 received in 2024. These payments were reported across 62 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,449).
As a Medicare-enrolled provider, Lyon has provided services to 885 Medicare beneficiaries, totaling 1,365 services with total Medicare billing of $96,748. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine
- Location Traverse City, MI
- Active Since 04/17/2007
- Last Updated 02/15/2024
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1528283199
Products in Payments
- TRELEGY ELLIPTA (Drug) $481.89
- Kerendia (Drug) $140.72
- SHINGRIX (Biological) $124.74
- UBRELVY (Drug) $49.34
- QULIPTA (Drug) $47.34
- Veozah (Drug) $38.68
- Saxenda (Drug) $36.93
- Wegovy (Drug) $33.15
- LONHALA MAGNAIR (Drug) $31.20
- MYRBETRIQ (Drug) $30.96
- Azstarys (Drug) $25.77
- ANORO ELLIPTA (Drug) $24.11
- Auvelity (Drug) $22.76
- EVENITY (Biological) $20.90
- AIMOVIG (Biological) $20.25
- Cologuard Collection Kit (Device) $17.63
- FLUBLOK QUADRIVALENT (Drug) $17.19
- NEXIUM (Drug) $17.01
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $16.09
- GARDASIL (Biological) $15.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.